Analysis of fractures in patients with type 2 diabetes treated with empagliflozin in pooled data from placebo-controlled trials and a head-to-head study versus glimepiride
Kohler S et al. Diabetes Care 2018: dc171525. doi: 10.2337/dc17-1525
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.